A detailed history of Fcpm Iii Services B.V. transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Fcpm Iii Services B.V. holds 2,390,050 shares of ACHL stock, worth $2.15 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,390,050
Previous 2,390,050 -0.0%
Holding current value
$2.15 Million
Previous $2.13 Billion 40.45%
% of portfolio
0.42%
Previous 0.63%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 07, 2024

BUY
$0.78 - $0.96 $1.86 Million - $2.29 Million
2,390,050 New
2,390,050 $2.13 Billion

Others Institutions Holding ACHL

About Achilles Therapeutics plc


  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $36.7M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Fcpm Iii Services B.V. Portfolio

Follow Fcpm Iii Services B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fcpm Iii Services B.V., based on Form 13F filings with the SEC.

News

Stay updated on Fcpm Iii Services B.V. with notifications on news.